Insmed Inc. buy Roth Mkm
Start price
17.04.26
/
50%
€122.46
Target price
17.04.27
€180.03
Performance (%)
-26.62%
Price
29.07.26
€90.43
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -26.62%. This prediction currently runs until 17.04.27. The prediction end date can be changed by Roth_Mkm at any time. Roth_Mkm has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.283% | -2.283% |
| iShares Core DAX® | 1.014% | 2.699% |
| iShares Nasdaq 100 | -6.470% | -8.771% |
| iShares Nikkei 225® | -6.517% | -12.580% |
| iShares S&P 500 | -2.721% | -1.752% |
Comments by Roth_Mkm for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its "buy" rating reaffirmed by Roth Mkm. They now have a $212.00 price target on the stock.
Ratings data for INSM provided by MarketBeat

